Middle East & Africa Stem Cell Therapy Market Outlook (2018 to 2032)
Synopsis
The above chart is Middle East & Africa Stem Cell Therapy Market Outlook (2018 to 2032)
Market Dynamics
the middle east and africa (mea) stem cell therapy market outlook is largely driven by positive reforms and policies across various countries in the region, coupled with strong government support. stem cell-based treatments have shown promising potential in treating various genetic, metabolic, hematological and immunological diseases. the advent of novel therapeutic stem cell technologies has opened a new horizon of treatment, and mea presents a great opportunity due to the presence of a fast-growing patient population.
given the anecdotal presence of stem cell related treatments, mea’s capabilities in stem cell therapy is slowly evolving; although still at early stages when compared with advanced markets such as the us and japan. several countries including kuwait, iraq, oman, uae, saudi arabia and qatar have made dedicated efforts in the area of stem cell research, resulting in encouraging outcomes. severe cases of anemia have been successfully treated with stem cell technology. by contrast, stem cell treatment remains in the early stages for cancer and degenerative disorders.
the research and development (r&d) of stem cell treatments is largely carried out at universities and academic research institutions. collaboration between healthcare and academic sectors is beneficial in scaling up the commercialization of stem cell technology. saudi arabia has witnessed state-of-the-art research facilities dedicated to stem cell therapy. across the region, there has been increased focus on organizations such as the international russian-arab center for stem cells and regenerative medicine, which specializes in stem cell-based therapies.
in order to drive the growth of stem cells therapies in mea, several strategic collaborations are in effect. for instance, scigenerastem, a dubai based biotechnology company has collaborated with the leading french biotechnology firm eurostemcell. the objective of the collaboration is to benefit from the experience of stem cell companies in the developed world, thereby replacing the traditional treatments with the advanced stem cell treatments.
though the pace of development is slow, countries such as uae and saudi arabia are ensuring the growth of stem cells therapies through government-backed initiatives and programs. these efforts are now beginning to pay dividends as the awareness of the benefits of stem cells are gradually increasing. establishment of advanced stem cell research and therapeutic centers, combined with the growing recognition and understanding of stem cell related treatments, will contribute to the growth of stem cell therapy market in mea.